Summary:
A Randomized, Single-Blind, Parallel-Group, Placebo-Controlled, Multidose Study Comparing the Therapeutic Equivalence of a 3M Inhaler and a Symbicort Reference Inhaler, Each Delivering Budesonide/Formoterol Fumarate (80ug/4.5ug) in Adult Subjects with Asthma
Qualified Participants Must:
Currently be nonsmoking including E-cigarettes within the past year and has less than 10 pack-years of historical use
Be Male or Female older than 18 years of age
If female of childbearing potential and committed to consistent and correct use of an acceptable method of birth control
Have been diagnosed by physician of Asthma at least 6 months prior to screening for study participation
Have stable asthma control on chronic asthma treatment regimen for at least 4 weeks prior to study visit
Qualified Participants May Receive:
$300-$500+ compensation, free treatment and doctor consultations with 24hr emergency phone line